Machine learning prediction model of transition from acute kidney injury to acute kidney disease after liver transplantation: a retrospective study
摘要
The transition from acute kidney injury (AKI) to acute kidney disease (AKD) is a frequent sequela after liver transplantation (LT), associated with increased short-term mortality, prolonged hospitalization, and increased likelihood of progression to chronic kidney disease. Early identification of high-risk patients remains a critical unmet need. This study aimed to develop a machine learning-based model for early prediction of AKI-to-AKD transition after LT.
MethodsPatients who underwent LT and developed postoperative AKI between January 2019 and December 2022 were enrolled as the development cohort (n = 359), randomly allocated into a training set and an internal validation set. Six machine learning algorithms were evaluated to construct prediction models. All models were subsequently assessed in a temporal validation cohort in the same medical center (n = 104 from January 2024 to December 2025). The Shapley Additive Explanations (SHAP) were used for model interpretation. An online risk calculator was developed based on the final model.
ResultsThe incidence of postoperative AKD in the training set was 57.1%. AKD progression was associated with 8 predictors: postoperative day 7 blood urea nitrogen (BUN), preoperative serum creatinine (Scr), postoperative day 7 sodium, calcineurin inhibitor overexposure, imipenem/cilastatin use, amphotericin B use, sex, and cefoperazone/sulbactam use. The logistic regression model demonstrated the best overall performance, with an AUC of 0.805 in the internal validation cohort and 0.809 in the temporal validation cohort, with good calibration. SHAP analysis indicated that postoperative BUN, preoperative Scr, and postoperative sodium were the most influential predictors. Decision curve analysis demonstrated net clinical benefit.
ConclusionThis study developed and temporally validated an interpretable predictive model for AKI-to-AKD transition after LT, which can facilitate early identification of high-risk patients and guide individualized nephroprotective strategies.